Allianz Asset Management GmbH - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,431,137
-8.4%
92,391
-5.7%
0.00%0.0%
Q1 2024$1,561,801
+57.1%
97,980
+65.7%
0.00%0.0%
Q4 2023$994,043
+43.8%
59,1340.0%0.00%
+100.0%
Q3 2023$691,276
-45.4%
59,134
-37.3%
0.00%
-50.0%
Q2 2023$1,266,801
-79.4%
94,256
-74.5%
0.00%
-81.8%
Q1 2023$6,135,546
-20.1%
370,057
-10.4%
0.01%
-26.7%
Q4 2022$7,678,731
+52.9%
412,835
+5.4%
0.02%
+50.0%
Q3 2022$5,023,000
-31.1%
391,504
-62.3%
0.01%
+42.9%
Q2 2022$7,287,000
-4.0%
1,039,545
+13.5%
0.01%
+16.7%
Q1 2022$7,590,000
+2948.2%
915,525
+2392.6%
0.01%
Q4 2021$249,000
+31.1%
36,730
+2.2%
0.00%
Q3 2021$190,000
-65.2%
35,931
-62.2%
0.00%
Q2 2021$546,000
-72.8%
94,966
-88.4%
0.00%
-100.0%
Q4 2015$2,011,000
-17.6%
820,853
+0.9%
0.00%
-33.3%
Q3 2015$2,440,000
+45.2%
813,346
+99.8%
0.00%
+50.0%
Q2 2015$1,681,000
+23.8%
407,019
+29.8%
0.00%0.0%
Q1 2015$1,358,000313,5230.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders